GYRE

GYRE R&D Expenses

$33.05MTTM · USD

Period ending:

GYRE FY R&D ExpensesUSD
GYRE FY R&D Expenses2001-12-31: $8.15M2002-12-31: $16.24M2003-12-31: $18.18M2004-12-31: $22.77M2005-12-31: $24.25M2006-12-31: $21.79M2007-12-31: $34.62M2008-12-31: $40.98M2009-12-31: $40.18M2010-12-31: $64.55M2011-12-31: $95.22M2012-12-31: $49.09M2013-12-31: $38.84M2014-12-31: $5.27M2015-12-31: $5.96M2016-12-31: $11.56M2017-12-31: $12.85M2018-12-31: $21.47M2019-12-31: $43.86M2020-12-31: $52.98M2021-12-31: $64.57M2022-12-31: $16.69M2023-12-31: $13.78M2024-12-31: $12.02M2025-12-31: $13.70M$95.22M$0.00
2001-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

GYRE r&d expenses history

Research and development spending. The available annual fiscal periods series contains 25 observations from Dec 31, 2001 to Dec 31, 2025.

Gyre Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
13,698,000
12,024,000
13,780,000
16,686,000
64,574,000
52,975,000
43,859,000
21,474,000
12,847,000
11,555,000
5,958,000
5,267,000
38,840,000
49,087,000
95,215,000
64,546,000
40,179,000
40,981,000
34,619,494
21,787,873
24,251,463
22,770,881
18,179,000
16,244,000
8,152,000

Compare r&d expenses

All GYRE financial metrics · GYRE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.